Sanofi CEO Garijo Aims To Reduce Dependence On Dupixent
28 Apr 2026 //
BIOSPACE
Sanofi Prices $2.3B Bond Issue
24 Apr 2026 //
GLOBENEWSWIRE
Gujarat Themis Biosyn Acquires Anti-Tb Brands From Sanofi
24 Apr 2026 //
INDPHARMAPOST
Sanofi Defends Dupixent Patents Amid CEO Change
23 Apr 2026 //
BIOSPACE
Sanofi Has `Vigorous Defense Planned` For Dupixent Patent Cliff
23 Apr 2026 //
FIERCE PHARMA
Sanofi CFO Defends Hudson`s Legacy, Accepts R&D `Setbacks`
23 Apr 2026 //
FIERCE BIOTECH
Sanofi `Fully Committed` to Garijo Appointment
23 Apr 2026 //
ENDPOINTS
Sanofi CEO Confronts Immunology R&D Strategy Challenge
22 Apr 2026 //
ENDPOINTS NEWS
Sanofi: Total Voting Rights and Shares as of Mar 2026
14 Apr 2026 //
GLOBENEWSWIRE
Sanofi to Hold Combined General Meeting on April 29
08 Apr 2026 //
GLOBENEWSWIRE
Novavax Boosts `Amplification Strategy` Through Sanofi, Pfizer
06 Apr 2026 //
FIERCE PHARMA
Q1 2026 Aide-Mémoire Now Available
24 Mar 2026 //
PRESS RELEASE
Sanofi Reports Total Voting Rights And Shares For February 2026
12 Mar 2026 //
GLOBENEWSWIRE
Sanofi Board Proposes Christel Heydemann As Independent Director
06 Mar 2026 //
PRESS RELEASE
Pharma Firm Files 2025 US 20-F and French Annual Report
17 Feb 2026 //
PRESS RELEASE
Drugmaker Sanofi To Expand India GCC, Increase Workforce
17 Feb 2026 //
ECONOMICTIMES
Merck KGaA`s Belen Garijo To Become CEO Of Sanofi
13 Feb 2026 //
INDPHARMAPOST
Sanofi Names Belén Garijo as New CEO
13 Feb 2026 //
PRESS RELEASE
Sanofi Discloses Voting Rights And Shares For January 2026
11 Feb 2026 //
GLOBENEWSWIRE
Sanofi Initiates €1B Share Buyback Mandate
03 Feb 2026 //
PRESS RELEASE
Amgen Exits $400M Autoimmune Pact After Running Vast Program
30 Jan 2026 //
FIERCE BIOTECH
Sanofi Keeps Mum On Denali Pact After Scrapping Final RIPK1 Drug
29 Jan 2026 //
FIERCE BIOTECH
BrightInsight Secures Multi-Million Investment For Ai Medication
20 Jan 2026 //
GLOBENEWSWIRE
Myqorzo And Redemplo Approved In China
17 Jan 2026 //
PRESS RELEASE
FDA Delays Decision On Lilly`s Obesity Drug Orforglipron
17 Jan 2026 //
REUTERS
Speculation Of Sanofi Takeover Sends Ocular`s Stock Soaring
16 Jan 2026 //
BIOSPACE
Sanofi Discloses Voting Rights And Shares For December 2025
14 Jan 2026 //
GLOBENEWSWIRE
Ahmed Moussa Appointed Country Lead For Sanofi UK & Ireland
14 Jan 2026 //
PHARMIWEB
Sanofi Invests $30M In Enable Injections For Manufacturing Boost
06 Jan 2026 //
GLOBENEWSWIRE
Sanofi Provides Update on Tolebrutinib Regulatory Submission
24 Dec 2025 //
PRESS RELEASE
Sanofi Strikes U.S. Deal to Cut Drug Costs, Boost Innovation
20 Dec 2025 //
GLOBENEWSWIRE
Sanofi Strikes U.S. Deal to Cut Drug Costs, Boost Innovation
19 Dec 2025 //
GLOBENEWSWIRE
Q4 2025 Aide-Mémoire Now Available
18 Dec 2025 //
PRESS RELEASE
NMPA Approves Aficamten for Hypertrophic Cardiomyopathy
17 Dec 2025 //
GLOBENEWSWIRE
Recludix Pharma Clears FDA For REX-8756, Oral STAT6 Inhibitor
16 Dec 2025 //
GLOBENEWSWIRE
Market update EUROAPI Strengthens Shareholder Commitment
16 Dec 2025 //
PRESS RELEASE
Finance Ministry Allows 15 Firms To Import Morphine, Codeine
12 Dec 2025 //
PHARMABIZ
Sanofi, GSK Ink Preclinical Pacts In Hunt For New Antibodies
10 Dec 2025 //
FIERCE BIOTECH
Trial Library Secures $10M Series A For Clinical Trial Access
02 Dec 2025 //
PHARMIWEB
Sanofi Discloses October 2025 Voting Rights & Shares
13 Nov 2025 //
GLOBENEWSWIRE
Drugmakers Push FDA To Extend Support To Existing Facilities
11 Nov 2025 //
BIOSPACE
Novavax Transfers U.S. Marketing Rights For Nuvaxovid
04 Nov 2025 //
PR NEWSWIRE
Press release: Sanofi successfully prices USD 3B of bond issue
28 Oct 2025 //
PRESS RELEASE
Sanofi India Appoints Deepak Arora As Managing Director
27 Oct 2025 //
ECONOMICTIMES
Sanofi`s Dupixent Reaches Quarterly Sales Of €4B For First Time
24 Oct 2025 //
FIERCE PHARMA
Press Release: Q3: Continued Sales And Earnings Progress
24 Oct 2025 //
PRESS RELEASE
Sanofi`s Wayrilz Recommended For EU Approval For thrombocytopenia
17 Oct 2025 //
PRESS RELEASE
Regeneron, Sanofi Receive 1- To 2-Month Priority Review Vouchers
17 Oct 2025 //
FIERCE BIOTECH
Europe`s CHMP Issues Negative Opinion On Sanofi`s Rezurock
17 Oct 2025 //
FIERCE PHARMA
US FDA Announces Recipients Of National Priority Vouchers
16 Oct 2025 //
REUTERS
Sanofi Discloses Voting Rights & Shares Data - Sep 2025
14 Oct 2025 //
GLOBENEWSWIRE
Sanofi $110 M Radioligand Therapy Hits Main Goal in Ph. 2 Trial
09 Oct 2025 //
PRESS RELEASE
Galderma`s Itch Relief Claims Scratched After Sanofi Complaint
08 Oct 2025 //
FIERCE PHARMA
Novavax Announces Progress On Sanofi Agreement
01 Oct 2025 //
PRESS RELEASE
Boryung Picks Up Taxotere Rights In Deal Worth Up To $205M
30 Sep 2025 //
FIERCE PHARMA
Sanofi Expands Price Cut To $35 Monthly For All Insulin Products
26 Sep 2025 //
FIERCE PHARMA
Immuneering Prices 175M Public Offering, Secures 25M in Placement
25 Sep 2025 //
GLOBENEWSWIRE
Press Release: Availability Of The Q3 2025 Aide Mémoire
24 Sep 2025 //
PRESS RELEASE
Sanofi`s Oral Ms Drug FDA Action Date Shifted To December
22 Sep 2025 //
BIOSPACE
Update on the US Regulatory Review of Tolebrutinib in MS
22 Sep 2025 //
PRESS RELEASE

Market Place
Sourcing Support